Table 2:
CVD+ (n = 7) | CVD− (n = 24) | p value | |
---|---|---|---|
Demographics | |||
Age | 13.2 (1.6) | 13.3 (2.4) | 0.85 |
Sex male | 2 (29%) | 13 (54%) | 0.39 |
Socioeconomic status index | 6.8 (4.8) | 7.5 (2.5) | 0.77 |
Health indicators | |||
Poor health by self-report | 1 (14%) | 2 (9%) | 1.00 |
History of malnutrition | 1 (14%) | 5 (21%) | 1.00 |
History of severe malnutrition | 1 (14%) | 2 (8%) | 0.55 |
Height % | 10 (6-27.5) | 4 (2-15) | 0.24 |
Weight % | 24 (10-42.5) | 4 (2-12.5) | 0.01** |
Number of hospitalizations | 1 (1-2) | 1 (1-2) | 0.92 |
History of malaria | 3 (43%) | 16 (67%) | 0.38 |
Cerebral malaria | 0 (0%) | 2 (8%) | 1.00 |
History of TB | 2 (29%) | 9 (38%) | 1.00 |
Opportunistic infections | 1 (0.5-1) | 0.5 (0-1.3) | 0.70 |
HIV specific factors | |||
Age of ART initiation | 5 (4-6) | 4 (2-7) | 0.61 |
Initiation of ART before 1 yr | 0 (0%) | 3 (13%) | 1.00 |
ART treatment interrupted | 1 (14%) | 2 (9%) | 1.00 |
ART adherence issues | 0 (0%) | 3 (13%) | 1.00 |
Worst WHO stage 4 | 2 (29%) | 11 (46%) | 0.67 |
Most recent CD4 < 200 | 0 (0%) | 1 (4%) | 1.00 |
Lowest CD4 | 372.1 (205.3) | 455.3 (210.2) | 0.37 |
Viral load ever detected | 3 (43%) | 11 (48%) | 1.00 |
Protease inhibitor any use | 2 (29%) | 13 (54%) | 0.39 |
Efavirenz any use | 6 (86%) | 14 (58%) | 0.37 |